RV1729
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RV1729, covering 2014-04-24 to 2015-07-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPD [Phase 1]